Study Examines Patients’ Perspectives on Deactivation of ICDs in End-of-Life

November 19, 2014

(Medical Xpress) – Most patients with implantable cardioverter defibrillators (ICDs)—small devices placed in a person’s chest to help treat irregular heartbeats with electrical pulses, or shocks—haven’t thought about device deactivation if they were to develop a serious illness from which they were not expected to recover. But given changes in healthcare, there may be a new reason to do so. A new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania, which was presented today at the 2014 Scientific Sessions of the American Heart Association, investigated patient perspectives on deactivation of these devices at the end of life, especially related to decisions to deactivate devices against patient or family wishes.